On Sept. 15, 2020, the University of Texas Health Science Center at Houston (UTHealth) announced that a study on the effectiveness of multiple treatments, including laboratory-made antibodies, at preventing mild COVID-19 from advancing to severe illness in the outpatient setting was underway. The clinical trial was enrolling patients at Harris Health Systemﾒs Lyndon B. Johnson Hospital.